Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WSL-HP |
Wild boar lung cells | Swine | respiratory system | cell line | adherent | plasmid | CRISPR | K2 Transfection System | publication | T. Kabuuka, Dissertation, 2020, Universität Greifswald | Link | ||
WSL |
Wild boar lung cells | Swine | respiratory system | unknown | adherent | plasmid | CRISPR | K2 Transfection System | publication | A. Hübner et al., Scientific Reports, 2018, 8: 1449, DOI:10.1038/s41598-018-19626-1 | Link | ||
SNU-449 |
Human hepatocellular carcinoma cell line | ATCC CRL-2234 | Human | digestive organs | cell line | adherent | sgRNA | CRISPR | Metafectene PRO | publication | R. Han et al., Scientific Reports, 2021, 11: 8626, doi.org/10.1038/s41598- | Link | |
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | D. Haslinger, Dissertation, 2018, Johann Wolfgang Goethe-Universität | Link | |
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | F. Longo et al., bioRxiv preprint, 2021, doi.org/10.1101/2021.03.16.435646 | Link | |
NCI-H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | C. Ren et al., J. Biol. Chem., Apr 2016; 291: 9629 - 9637 | Link | |
NCI-H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | sgRNA | CRISPR | Metafectene PRO | publication | C. Ren et al., J. Biol. Chem., Apr 2016; 291: 9629 - 9637 | Link | |
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | sgRNA | CRISPR | Metafectene PRO | publication | C. Ren et al., J. Biol. Chem., Apr 2016; 291: 9629 - 9637 | Link | |
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | C. Ren et al., J. Biol. Chem., Apr 2016; 291: 9629 - 9637 | Link | |
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | B. von Neubeck et al., Int. J. of Cancer, 2018, 143: 2065–2075, DOI: 10.1002/ijc.31607 | ||
M14 |
Human metastatic melanoma cells | Human | skin | cell line | adherent | plasmid | CRISPR | Metafectene SI | publication | A. Sarma et al., The American J. of Pathology, 2021, 191, 2, doi.org/10.1016/j.ajpath.2020.10.015 | Link | ||
Hep-3B |
Human hepatocellular carcinoma cell line | ATCC HB-8064 | Human | digestive organs | cell line | adherent | plasmid | CRISPR | Metafectene | publication | Y.-R. Kim et al., Exp. & Mol. Medicine, 2019, 51 :129, doi.org/10.1038/s12276-019-0340-1 | Link | |
Hep-3B |
Human hepatocellular carcinoma cell line | ATCC HB-8064 | Human | digestive organs | cell line | adherent | sgRNA | CRISPR | Metafectene PRO | publication | R. Han et al., Scientific Reports, 2021, 11: 8626, doi.org/10.1038/s41598- | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | A. J. Jakobi et al., Nature Communications, 2020, 11: 440, doi.org/10.1038/s41467-020-14343-8 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | Y. P. Abudu et al., J. Cell Biol., 2021, 220(8): e202009092, doi: 10.1083/jcb.202009092 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | CRISPR | Metafectene PRO | publication | S. Kumar et al., Dev. Cell., 2019, 49(1): 130–144.e6., doi:10.1016/j.devcel.2019.01.027. | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | A.J. Jakobi et al., Nature Communications, 2020, 11: 440, doi.org/10.1038/s41467-020-14343-8 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | CRISPR | Metafectene PRO | publication | S. Kumar et al., Dev. Cell., 2019, 49(1): 130–144.e6., doi:10.1016/j.devcel.2019.01.027. | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | CRISPR | K2 Transfection System | publication | R. Roman et al., BMC Proceedings, 2020, 14 (Suppl 5): P-112 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | CRISPR | Metafectene | publication | J. Ohnheiser et al., Biochim. et Biophys. Acta, 2015, 1853: 1564-1573; doi.org/10.1016/j.bbamcr.2015.03.008 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | D. P. Reguera et al., Cells, 2020, 9: 443, doi:10.3390/cells9020443 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | CRISPR | Metafectene | publication | A. de Araujo Brasil et al., PNAS, 2019, 116, 51: 25991–26000, doi/10.1073/pnas.1902483116 | Link | |
HECa10 |
Mouse endothelial cells of peripheral lymph nodes | Mouse | immune system | cell line | adherent | plasmid | CRISPR | K2 Transfection System | publication | P. Janus et al., Cell Death & Differentiation, 2020, 27: 2280–2292, doi.org/10.1038/s41418-020-0501-8 | Link | ||
HCT116 p53 -/- |
Human colon adenocarcinoma cell line deficient of p53 | Human | digestive organs | cell line | adherent | sgRNA | CRISPR | Metafectene PRO | publication | C. Ren et al., J. Biol. Chem., Apr 2016; 291: 9629 - 9637 | Link | ||
HCT116 p53 -/- |
Human colon adenocarcinoma cell line deficient of p53 | Human | digestive organs | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | C. Ren et al., J. Biol. Chem., Apr 2016; 291: 9629 - 9637 | Link |